Factors that contribute to loss to follow-up in the medium term after initiation of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration in Japanese patients

Sugisawa, Takaaki; Gomi, Fumi; Harada, Yuri; Imaizumi, Hiroko; Aoki, Shuichiro; Miki, Akiko; Kishi, Maya; Yamauchi, Tomofusa; Nagasato, Daisuke; Ozawa, Yoko; Haruta, Masatoshi; Kato, Nobuhiro; Matsubara, Hisashi; Yasukawa, Tsutomu; Kato, Aki; Terasaki, Hiroto; Hirano, Takao; Iesato, Yasuhiro; Tsujinaka, Hiroki; Murakami, Tomoya; Mitamura, Yoshinori; Wakuta, Makiko; Kimura, Kazuhiro; Shimura, Masahiko

doi:10.1371/journal.pone.0325963

Public

Factors that contribute to loss to follow-up in the medium term after initiation of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration in Japanese patients

Published in PLoS ONE • Jun 11, 2025

Authors:

Takaaki Sugisawa

Fumi Gomi

Yuri Harada

Abstract

PURPOSE: To identify time-specific factors associated with loss to follow-up (LTFU) in the early to medium term after initiating anti-vascular endothelial growth factor (VEGF) treatment in patients with neovascular age-related macular degeneration (nAMD) in Japan. METHODS: The study had a retrospect...

Subject

Macular degeneration

Medicine

Vascular endothelial growth factor A

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!